Age-stratified outcomes of bioprosthetic and mechanical aortic valve replacements in an Australian cohort of 13 377 patients.
Oluwadamisola Temilade SotadeMichael O FalsterLeonard N GirardiSallie-Anne PearsonLouisa R JormPublished in: BMJ surgery, interventions, & health technologies (2020)
This study provides real-world evidence of AVR use and outcomes. Use of BV implants is increasing irrespective of age. Valve choice in younger patients requires thorough evaluation of patient factors influencing both short-term outcomes and longer-term risks of reoperation, stroke and hemorrhage.
Keyphrases
- aortic valve
- end stage renal disease
- ejection fraction
- aortic stenosis
- transcatheter aortic valve replacement
- aortic valve replacement
- newly diagnosed
- chronic kidney disease
- transcatheter aortic valve implantation
- prognostic factors
- atrial fibrillation
- metabolic syndrome
- preterm infants
- coronary artery disease
- climate change
- risk assessment
- lps induced
- insulin resistance
- patient reported
- gestational age
- weight loss
- human health